News
Why US-EU trade deal faces jeopardy over ambiguous pharmaceutical tariffs
Pharmaceutical companies are seeking clarification on tariffs imposed under the new US-EU trade agreement . Analysts caution that sector-specific punitive levies could jeopardise the entire deal, according to a CNBC report.
Stellantis said on Tuesday it faced greater headwinds this year including a 1.5-billion-euro impact from U.S. tariffs for ...
Automaker warns of massive hits to earnings from President Trump's tariffs, as it take steps to build more vehicles in U.S.
Higher tariffs, or import taxes, on European goods mean sellers in the U.S. would have to either increase prices for ...
The 15% tariff would be lower than previously threatened, but it would remain a high duty on America’s largest trading ...
The benchmark STOXX 600 rose 0.9% to hit a four-month high early in Monday's session but reversed course to close about 0.2% ...
The White House has confirmed that the 15% tariff agreed between the European Union and the United States includes pharmaceuticals and semiconductors.
Jeep owner Stellantis said on Monday it suffered a massive loss in the first half of the year, when it felt the first impact ...
A threatened 30% tariff on European wines would hurt many U.S. companies while hiking prices at home and in restaurants, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback